hotspot -WSS

hotspot

author：leisure time 2025-09-02 08:09:04 - browse：65752

Why are addiction treatments so hard to get? Can small companies compete in obesity? And since when is “Series E” a thing in biotech?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. For the entirety of the opioid overdose epidemic, the U.S. has had readily available tools that are proven to save lives. STAT’s Lev Facher joins us to explain his reporting on why virtually every sector of American society is standing in the way of their use. We also discuss the latest news in the life sciences, including the haves and have-nots of venture capital, and the race to develop effective oral treatments for obesity.

For more on what we cover, here’s the story on addiction medicine; here’s the latest on biotech financing; here’s more on Novo Nordisk’s oral obesity treatment; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Digital health: a case of mistaken identity

focus

WSS

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

ASCO eve: Let’s set the table for this year's meeting

'Make People Better': The CRISPR babies story you probably don't know

AstraZeneca chief proposes a novel edit to the drug pricing bill

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

focus

hotspot

entertainment

How to save PrEP access — and even expand it

H5N1 virus can be tracked in retail milk, scientists say

Dobbs anniversary: the lost opportunity of abortion as health care

Listen: Biogen's potential pivot, & Illumina's next chapter

Dobbs anniversary: the lost opportunity of abortion as health care

Reports of telehealth's death have been greatly exaggerated

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Scrutiny of post

23andMe had bad news about my health. I wish a person had delivered it

UnitedHealth argues against case alleging wrongful AI care denials

leisure time

FDA poised to publish guidelines for clinical trial diversity

FDA poised to publish guidelines for clinical trial diversity

Medicaid rebukes states for mistakenly disenrolling children

Eyeing GLP

Fentanyl is making it harder to start addiction treatment

UnitedHealth argues against case alleging wrongful AI care denials

explore

Wikipedia

focus

focus